✦ LIBER ✦

Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients

✍ Scribed by D. J. Moss; S. H. Chan; S. R. Burrows; T. S. Chew; R. G. Kane; J. A. Staples; N. Kunaratnam

Book ID: 118283963
Publisher: John Wiley and Sons
Year: 1983
Tongue: French
Weight: 501 KB
Volume: 32
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910320307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive transfer of autologous Epstein-

Adoptive transfer of autologous Epstein-Barr virus–specific cytotoxic T cells for nasopharyngeal carcinoma

✍ Daniel Chua; Jie Huang; Bojian Zheng; See Yan Lau; Winsie Luk; Dora L.W. Kwong; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 1 views

Tumor cells from NPC patients are regularly and latently infected with EBV. To examine whether the virus serves as target for immune intervention of the cancer, we determined levels of EBV-specific CTLp in peripheral blood from NPC patients, long-term survivors of the cancer and healthy subjects. CT

Interleukin-10 expression and cytotoxic-

Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma

✍ Min Yao; Koichi Ohshima; Junji Suzumiya; Tohru Kume; Toyo-o Shiroshita; Masahiro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 193 KB 👁 2 views

Interleukin-10 (IL-10) is an inhibitory cytokine produced by various cell types. It exhibits strong sequence homology to BCRF-1 (viral IL-10, vIL-10), an open reading frame in the Epstein-Barr-virus (EBV) genome. Using in situ hybridization (ISH), polymerase chain reaction (PCR) and immunohistochemi

Therapeutic targeting of regulatory T ce

Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein–Barr virus associated nasopharyngeal carcinoma

✍ Fogg, Mark; Murphy, John R.; Lorch, Jochen; Posner, Marshall; Wang, Fred 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 981 KB

Impaired Long-term T Cell Immunity to Ep

Impaired Long-term T Cell Immunity to Epstein-Barr Virus in Patients with Nasopharyngeal Carcinoma

✍ Tamura, Shinji ;Yamazaki, Atsushi ;Kunimoto, Masaru ;Takemura, Kiyoshi ;Tabata, 📂 Article 📅 1992 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 319 KB

Epstein-Barr virus-specific cytotoxic T

Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients

✍ J. S. H. Gaston; A. B. Rickinson; M. A. Epstein 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 445 KB

The level of Epstein-Barr (EB) virus-specific cytotoxic T cell responsiveness was measured in 21 patients with active, progressive rheumatoid arthritis (RA). A significant number (8 out of 20) of EB virus sero-positive patients showed a markedly impaired responsiveness when compared with a control g

CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR V

CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN NASOPHARYNGEAL CARCINOMA

✍ Chan, S.H.; Chew, T.S.; Kunaratnam, N. 📂 Article 📅 1979 🏛 The Lancet 🌐 English ⚖ 267 KB